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THE OCULAR MANIFESTATIONS OF CHRONIC TRAUMATIC 
ENCEPHALOPATHY  
NATHALIE SLICK 
ABSTRACT 
 Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative 
disease that is characterized by a tauopathy in the form of aggregates of 
hyperphosphorylated tau throughout the CNS.  Individuals suffering from CTE 
experience many different symptoms that result in dementia and severe cognitive decline 
along with a heightened occurrence of suicide. Repetitive mild traumatic brain injuries, 
such as concussions or subconcussive blows, are responsible for the development of 
CTE. Therefore, individuals who participate in contact sports, such as football and 
hockey, are at a high risk of developing this disease.  
Currently, there is no method for detecting CTE during life and the diagnosis can 
only be made at autopsy. At present nothing is known about the eye pathology of CTE. 
But if a distinctive profile of ocular abnormalities could be identified, it would raise the 
possibility that CTE could be diagnosed during life by an eye exam.  
For this research, ten eyes of individuals suffering from varying stages of CTE 
were collected, dissected, and observed under a microscope to find pathology associated 
with CTE. The antibodies of interest are pTDP-43, p62, αβ crystallin, and CP13. 
Pathology was found in the retina, mostly in the ganglion cell layer, throughout the 
different stages of CTE with the most severe pathology occurring in the most severe 
cases. These results can serve as a foundation for continued CTE research in the eye and 
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ultimately result in potential ophthalmological diagnostic tests in individuals suffering 
from CTE.   
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INTRODUCTION 
 
Chronic traumatic encephalopathy (CTE) is a slowly progressive 
neurodegenerative disease that is clinically associated with symptoms such as 
impulsivity, irritability, aggression, and short-term memory loss (McKee et al., 2009). It 
is also associated with a heightened incidence of suicide that can occur about eight years 
after experiencing concussive trauma (McKee et al., 2009). CTE begins as an insidious 
tauopathy that is characterized by an increased amount of hyperphosphorylated tau 
protein that is deposited as neurofibrillary tangles in the brain (McKee et al., 2013). This 
disease was initially discovered in the 1920s by Harrison Martland and was later termed 
dementia pugilistica. It was initially found in boxers and believed to be caused by 
repetitive hits to the head (McKee et al., 2009). Martland described individuals suffering 
from this disease as “punch drunk” in which they displayed many of the same symptoms 
that are seen in individuals who suffer from chronic traumatic encephalopathy today 
(McKee et al., 2009). 
Individuals who suffer from CTE have experienced multiple mild traumatic brain 
injuries throughout their lifetime. These mild traumatic brain injuries are also known as 
concussions and are frequently seen in individuals who participate in contact sports such 
as football and hockey. Although it is not known how many head injuries a person can 
sustain before developing CTE, it is known that these injuries are responsible for the 
development of the disease.  
 
 2 
 
 
Concussive injury  
 
A concussion is considered a mild traumatic brain injury (mTBI) that results from 
a force that is applied to the head, neck, or face (McKee et al., 2014). To understand the 
pathology of chronic traumatic encephalopathy, it is important to understand how 
concussive brain injury can occur. There are two different types of forces that are 
responsible for the damage caused by concussion: linear acceleration and rotational 
acceleration. Linear acceleration can lead to an increase in pressure inside of the brain as 
well as damage to areas away from the site of impact. This phenomenon is known as 
coup-countercoup (Cockerham et al., 2013). The second type of force, rotational 
acceleration, leads to more tissue damage and is responsible for shear forces throughout 
the brain (Cockerham et al., 2013). These forces cause the brain to deform and alter 
neurons, blood vessels, and the permeability of the neuronal and axonal membranes 
(McKee et al., 2014). Linear and rotational acceleration are responsible for initiating the 
cascade of damage seen in individuals who suffer from multiple concussions. 
 Many symptoms that surround a concussion will abate over a short period of time; 
however, symptoms that last longer that 3 months result in a condition called post-
concussion syndrome (PCS) (McKee et al., 2014). Concussion and PCS symptoms can 
include loss of consciousness, depression, headaches, cognitive impairments, and 
emotional instability (McKee et al., 2014). Neuropsychological testing shows that 
individuals with PCS display persistent cognitive deficits that can affect the way these 
individuals make decisions (McKee et al., 2014). 
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 Impacts that seem less damaging than concussions but show similar changes in 
functional MRI are known as subconcussions (McKee et al., 2014). Subconcussions can 
have a fairly serious impact over time in many sports, most notably football. For 
example, a college offensive lineman can experience over a thousand subconcussive hits 
in one season (Crisco et al., 2010). These repetitive hits can lead to long-term 
consequences ultimately resulting in chronic traumatic encephalopathy. 
 
Gross pathology of CTE 
 
 Much of the gross neuropathology of CTE does not present itself until the later 
stages of the disease (Stern et al., 2011). As the stages progress, there is a reduction in 
the brain weight due to atrophy in multiple areas of the brain (McKee et al., 2009). The 
most severe areas of atrophy are in the medial temporal lobes and the frontal lobe of the 
brain (Stern et al., 2011). The important structures located in the medial temporal lobe 
are the amygdala and hippocampus, which are involved in emotion and memory. This 
explains the symptoms of emotional instability and dementia, which are associated with 
CTE. Another pathology is the increase in size of the lateral and third ventricles and a 
cavum septum pellucidum with holes or fenestrations throughout (McKee et al., 2009). 
There is thinning of the corpus callosum along with neuronal loss in the cerebellar tonsils 
(McKee et al., 2009). 
 Other pathologies seen in CTE include a pallor of the substantia nigra and locus 
coeruleus. In addition to atrophy of the medial temporal and frontal lobe, there is atrophy 
of the entorhinal cortex, olfactory bulbs, thalamus, mammillary bodies, brainstem, and 
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cerebellum (McKee et al., 2009). Figure 1 shows the gross pathology previously 
discussed. 
 
 
Figure 1: Gross Pathology of CTE. This figure shows the gross structural abnormalities 
associated with chronic traumatic encephalopathy. This figure is amended by arrows to 
help focus the specific structures. There is enlargement of the later ventricles (1), 
enlargement of the third ventricle (2), a cavum septum pellucidum (3), atrophy of medial 
temporal structures such as the amygdala, hippocampus, etc. (4), and atrophy of the 
mammilary bodies (5). (Figure 1 taken from Stern et al., 2011) 
 
Pathological and clinical manifestations of CTE 
There are many structural pathologies associated with CTE. This 
neurodegenerative disease is seen in individuals who have suffered multiple concussions 
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or repetitive mild traumatic brain injury, which can be seen in a large amount of contact 
or collision sports such as football and boxing among many other sports. (McKee et al., 
2013). Today, much attention is paid to injured professional football players who exhibit 
symptoms associated with chronic traumatic encephalopathy due to multiple concussions 
acquired throughout their career.  The symptoms and the severity of the disease correlates 
with the period of time played in the sport as well as the number of head injuries 
sustained (McKee et al., 2009). The symptoms tend to manifest midlife even though the 
pathology could be progressing from early adolescence (Stern et al., 2011). The 
progression of symptoms is slow and occurs over several decades (Stern et al., 2011).  
The clinical severity of the disease is explained by 4 different pathologic stages 
(Figure 2). The pathological features of stage 1 CTE includes areas of perivascular 
hyperphosphorylated tau neurofibrillary tangles (NFTs) along with enlarged lateral 
ventricles. It is also characterized by astrocytic tangles located in the sulci of the brain 
(McKee et al., 2013). Although people suffering from stage 1 CTE may be asymptomatic 
and clinically unremarkable, there are symptoms associated with this stage. Clinically, 
stage 1 CTE individuals suffer from short-term memory loss, attention and concentration 
loss, depression, and headaches (McKee et al., 2013). 
Stage 2 CTE pathology consists of enlargement of the ventricles along with a pale 
color of the substantia nigra and locus coerulus (McKee et al., 2013). There is a low 
density of tangles and pretangles located in the “hypothalamus, CA1 of the hippocampus, 
entorhinal cortex, thalamus, substantia nigra, and dorsal and medial raphe nuclei of the 
midbrain” (McKee et al., 2013). Clinically, these individuals suffer from the same 
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symptoms of the stage 1 individuals but to a higher degree. People with stage 2 CTE may 
have issues making decision and issues with language along with a propensity to commit 
suicide (McKee et al., 2013). 
The pathology of stage 3 CTE consists of abnormalities of the septum pellucidum 
(cavum septum pellucidum with or without fenestrations or absence of the septum 
pellucidum completely), enlargement of both the lateral and third ventricles, pale color of 
substantia nigra and locus coerulus, increased tangles in multiple areas of the brain such 
as the olfactory bulbs, hypothalamus, substantia nigra, hippocampus, amygdala, etc. 
(McKee et al., 2013). The clinical symptoms of Stage 3 CTE are more severe. Individuals 
suffer from explosivity, memory loss, executive dysfunction, depression, and aggression. 
Visuospatial difficulties present themselves in this stage (McKee et al., 2013). 
Stage 4 CTE, the most severe stage, consists of the pathology seen in prior stages 
but to a higher degree. There is atrophy of the cerebral cortex as well as the white matter 
with the most significant atrophy in the medial temporal lobe, thalamus, hypothalamus, 
and mammillary bodies.  The widespread atrophy also leads to a smaller brain weight 
than that seen in earlier stages of CTE (McKee et al., 2013). There is more severe 
enlargement of the ventricles along with an increased number of neurofibrillary tangles 
(McKee et al., 2013). This stage is also characterized by severe neuronal loss (McKee et 
al., 2013). Clinically, stage 4 CTE individuals suffer from extreme memory loss and 
dementia along with increased severity of clinical symptoms seen in stages one through 
three including aggression, depression, and visuospatial difficulties (McKee et al., 2013). 
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Figure 2: Stages of CTE. This figure shows the progression of hyperphosphorylated tau 
deposits as the stages progress. The darkened areas of brown/black indicate the areas of 
hyperphosphorylated tau. The higher the stage, the more severe the pathology. (Figure 2 
taken from McKee et al., 2012) 
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Correlation between pathology and clinical symptoms in CTE 
 The pathology seen in the frontal cortex, specifically the dorsolateral, lateral, and 
superior frontal cortex, contributes to the individual’s issues with executive function as 
well as noticeable personality changes (McKee et al., 2013). This also attributes to the 
lack of inhibition seen by many people who suffer from CTE (McKee et al., 2013). The 
atrophy of the amygdala along with atrophy of the inferior temporal cortex contributes to 
the aggressiveness seen in CTE individuals (McKee et al., 2013). These patients suffer 
from explosive and impulsive behavior changes.  
Another area affected by CTE is the locus coeruleus. The pathology seen in this 
area may explain the depression and mood changes in CTE patients (McKee et al., 2013). 
The atrophy of the mammillary body and hippocampus explains the issues with memory 
and cognitive deficits that manifest in these individuals (McKee et al., 2013). This also 
contributes to the progressive dementia over time.  
  
Potential risk factors for CTE 
Individuals who suffer repetitive mTBI throughout life are at risk for 
developing CTE; however, not everyone who is exposed to multiple concussions 
suffers from CTE. This leads to the possibility that there are potential risk factors 
that may increase the likelihood of an individual developing CTE. One potential risk 
factor is the ε4 allele of the apolipoprotein E (APOE) gene. This gene has been linked 
to an increased recovery time after mTBI (Stern et al., 2011). It has also been linked 
to cognitive deficiencies in boxers and football players (Stern et al., 2011).  
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  Another potential risk factor could be the sport and the position played in a 
sport. For example, an offensive lineman in football receives more hits that any 
other position in football (Stern et al., 2011). This leads one to conclude that a more 
physical position with higher potential for concussive and subconcussive hits would 
have a higher probability of developing CTE. Another sport that could have potential 
dangers for CTE is soccer. Soccer players often practice heading the ball, which puts 
them at a higher risk of developing CTE. 
 The number of injuries as well as the time of rest between each individual 
injury could potentially have an effect on the development of CTE (Stern et al., 
2011). Although this is not fully understood, there seems to be a correlation 
between the number of years played in a sport and the number of head injuries 
sustained with the likelihood of developing CTE.  If an athlete does not refrain from 
play for a proper amount of time after a concussion, they are potentially increasing 
their chances of developing more serious pathology that could lead to CTE (Stern et 
al., 2011). 
 Age and gender could also be potential risk factors for CTE. Research shows 
that younger individuals are more prone to diffuse brain injury, which can lead to 
more serious and prolonged cognitive deficits (Stern et al., 2011). Women tend to be 
more susceptible to PCS and concussions but that could also be due to the fact that 
women may be reporting symptoms and injury more than men (Stern et al., 2011). 
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However regardless of a risk factor, once CTE develops and begins to progress, it 
progresses in the absence of further head trauma (McKee et al., 2009). 
 
Sports and CTE 
 
 One of the sports known for its CTE exposure is American football. About 
50% of cases with CTE from the mTBI brain bank at the VA Boston/Boston 
University School of Medicine are from football players of whom about 75% had 
played at the professional level (McKee et al., 2014). These individuals endure many 
concussive and subconcussive blows throughout their athletic careers. As stated 
before, the position played along with the number of years played can have a 
significant impact in the development of CTE.   
 Soccer players are also at risk for development of CTE due to the practice of 
heading the ball. There have also been a high number of professional soccer players 
that suffer from motor neuron disease (MND) along with CTE, which could 
potentially be due to the spinal and brain injuries obtained from heading the ball 
(McKee et al., 2014). Rugby, another sport in which the players participate without 
the use of helmets, is another sport in which the players are at risk for developing 
CTE. 
 Although the impacts are much different than those suffered in football, 
hockey players experience brain trauma that put them at risk for CTE. Currently, of 
the 5 cases of former hockey players diagnosed with CTE, 3 of them played the 
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position of enforcer (McKee et al., 2014). This reinforces the fact that the position 
played can play a significant role in the risk of developing CTE. 
 
TDP-43 pathology and its relationship to neurodegenerative diseases 
 
 TDP-43 is an RNA-binding protein that is important in controlling RNA 
metabolism (McKee et al., 2014). Animal models show that when there is an acute 
injury, TDP-43 is upregulated and accumulates in the cytoplasm of cells (McKee et 
al., 2014). TDP-43 has important significance in relation to CTE because TDP-43 
could influence the expression of tau isoforms as well as affect tau protein 
metabolism leading to the aggregation and hyperphosphorylation of tau (McKee et 
al., 2014). The abnormal metabolism of TDP-43 can be seen in neurodegenerative 
diseases such as frontotemporal lobar degeneration (FTLD) and amyotrophic lateral 
sclerosis (ALS) (McKee et al., 2014). 
 
CTE and comorbidity with other neurodegenerative diseases 
Research shows that there can be a comorbidity of CTE with other 
neurodegenerative diseases such as FTLD, Alzheimer’s disease (AD), Lewy body 
disease (LBD), and motor neuron disease (MND) (McKee et al., 2014).  CTE exhibits 
some of the symptoms associated with FTLD. Those symptoms include dysfunction 
of the frontal and temporal lobes resulting in cognitive deficits (McKee et al., 2014). 
There is also neuronal loss as well as tau deposition (McKee et al., 2014). 
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There is increasing evidence that trauma and athletic injury can increase the 
chances of developing ALS. 13% of all cases that have been diagnosed with CTE have 
been comorbid with MND (McKee et al., 2014). The individuals who suffer from 
motor symptoms associated with MND die with a lower stage of CTE due to the fact 
that the lifespan is shorter (McKee et al., 2014). The individuals who show cognitive 
symptoms die at a higher stage of CTE (McKee et al., 2014). 
 
Anatomy and Function of the Retina 
As stated above, there are visiospatial deficits experienced by individuals who 
suffer from CTE. Since the eye is considered an extension of the CNS, it is clear that its 
pathology can have serious implications in the development and diagnosis of disease. 
This study focused primarily on the retina and the layers within it (Figure 3). 
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Figure 3: Anatomy of the Eye. This figure represents the overall anatomy of the eye. 
The main focus for this research is the retina and the 10 layers that comprise it. (Figure 3 
taken from http://www.centralillinoisvision.com/resources/eye_disease_information) 
 
Embryologically, the retina is derived from the neural tube, which is also 
responsible for the development of the central nervous system (Guo et al., 2010).  It 
consists of ten layers which are made up of five types of neurons: photoreceptor cells, 
bipolar cells, horizontal cells, amacrine cells, and retinal ganglion cells which can be seen 
in Figure 4 (Guo et al., 2010).   
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Figure 4: Layers of the retina. The figure shows the 10 layers of the retina, 6 of which 
are labeled. On the right, the figure shows the cells located in their corresponding layers. 
(Figure 4 taken from Guo, et al., 2010) 
 
In order to understand the pathology of the eye it is essential to review the 
function of the different neurons of the retina. The photoreceptors consist of two different 
types of cells: rods and cones. The rods are responsible for black and white vision and are 
highly sensitive to light whereas cones are responsible for sharp colorful vision and are 
relatively insensitive to light (Puryes et al., 2001). The bipolar cells are in contact with 
the photoreceptor cells and link the photoreceptor cells to the dendrites of the ganglion 
cells.  Horizontal cells provide a linkage between the photoreceptor cells and the 
dendrites of the bipolar cells and the amarcrine cells mediate interactions between the 
bipolar cells and the dendrites of the ganglion cells (Puryes et al., 2010). The final neuron 
of the retina is the retinal ganglion cell. This neuron is responsible for conveying the 
images perceived from the retina and sending it to the visual centers of the brain 
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(Sernagor et al., 2001). It is the last neuron before the formation of the optic nerve which 
forms synapse in the lateral geniculate nucleus in the thalamus of the brain (Ho et al., 
2012). Therefore, it can be seen that the retina, which ultimately forms synapses in the 
brain, can be indicative of changes occurring in the brain. 
 
Alzheimer’s Disease 
Since chronic traumatic encephalopathy is a progressive neurodegenerative 
disease, it is useful to compare it to another neurodegenerative disease, Alzheimer’s 
disease. This is especially useful in understanding the ocular manifestations of CTE.  AD 
is a neurodegenerative disease that affects more than 26.6 million people worldwide and 
is expected to quadruple in incidence by 2050 (Parnell et al., 2012).  The pathology 
associated with AD consists of senile plaques that are composed of amyloid-beta and 
neurofibrillary tangles which is composed of hyperphosphorylated aggregated tau protein 
(Parnell et al., 2012).  Macroscopically, AD is characterized by a cortical atrophy of the 
medial temporal lobes as well as dilations of the ventricles (Serrano-Pozo et al., 2011).  
There is also noticeable atrophy of the hippocampus (Sabunchu et al., 2011). Another 
important element of both AD and CTE is tau. Tau is a protein that is needed for 
microtubule assembly but its hyperphosphorylation leads to the pathology in many 
neurodegenerative diseases (Ho et al., 2012). For this research, Alzheimer’s disease and 
the ocular pathology associated with it will be used as a template to explain the ocular 
manifestations of chronic traumatic encephalopathy due to their similar pathological 
features.  
 16 
 
 
Ocular Pathology Associated with AD 
It has been reported that individuals suffering from Alzheimer’s disease 
experience abnormalities associated with the visual pathway. In vivo studies have shown 
there to be a decrease in the number of retinal ganglion cells within the retina as well as a 
reduction in the thickness of the retinal nerve fiber layer (Parnell et al., 2012).  A 
reduction in thickness of the RNFL is indicative of changes in the axons of the retinal 
ganglion cells (Guo et al., 2010). In transgenic mouse models, tau protein was found in 
the GCL as well as the RNFL (Parnell et al., 2012).  Individuals with Alzheimer’s disease 
experience difficulties with visual tasks such as depth perception, color recognition, 
visual attention, and difficulty reading (Guo et al., 2010). 
 
Difference in pathology between AD and CTE 
It is important to distinguish the pathology seen in AD from the pathology seen in 
CTE.  In CTE, tau abnormalities are focused to areas around small blood vessels, the 
sulci in brain tissue, and in the superficial layers of the cortex (Stern et al., 2011). This 
differs from that seen in AD. Also, there is no PHF-tau pathology in the medial-temporal 
lobes in the earlier stages of CTE while this kind of pathology is seen as a significant 
marker of AD in the preclinical stages (McKee et al., 2014). Another difference in the 
pathology of AD and CTE is that there are prominent astrocytic tangles in CTE while 
astrocytic tangles are not present in AD (McKee et al., 2013). It is also significant to note 
that the timeline of symptoms present themselves much earlier in CTE than they do in 
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AD. CTE symptoms manifest midlife while AD symptoms tend to arise in the seventh or 
eighth decade of life  
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OBJECTIVES  
The objective of the present study is find the ocular manifestations of chronic 
traumatic encephalopathy and find the relationship between the pathology seen in the 
brain and the pathology seen in the retina. Specifically: 
1) Data from ten eyes of individuals diagnosed with varying stages of CTE 
will dissected, cut, and stained with pTDP-43, p62, αβ crystallin, and 
CP13 
2) Overall positivity will be observed and recorded according to layer of the 
retina. The data collected will be displayed in graphs while images were 
put into figures. 
3) The goal is to determine if the pathology seen in the brain of CTE 
individuals is also represented in the eye. Therefore, making it possible to 
use ophthalmological eye exams as a way to diagnose CTE in a living 
individual. 
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METHODS  
 
 In order to determine how the eyes are affected in chronic traumatic 
encephalopathy (CTE), 10 eyes of individuals diagnosed with varying stages of CTE 
were used for this study.  The eyes ranged from stage 2 through stage 4 and included 3 
cases that were diagnosed with Amyotrophic Lateral Sclerosis (ALS) as well. In addition 
to the 10 CTE eyes, there were 8 controls obtained from Dr. John Crary from Columbia 
University Medical Center. Of the 10 CTE cases, there were 4 individuals who played 
professional football in the National Football League, 2 boxers (one of which an amateur 
boxer), and 1 professional rugby player. Each eye was processed, cut, and stained with 
antibodies against pTDP43, p62, αβ crystalline, and CP13 and observed for pathology 
associated with CTE. This study focused specifically on the retina and the ten layers that 
comprise it.   
 The eyes were dissected using ophthalmological protocols by removing the 
calottes to expose the central section, which includes the optic nerve head. The eyes were 
then fixed in formalin and embedded in paraffin. Sections of the blocks were cut at 10 
microns thick on a Leica M2255 microtome.  
A standard protocol was used for paraffin immunohistochemistry staining. 
First, the slides were de-paraffinized in xylene for a period of 10 minutes each for 3 
times. Then they were transferred into absolute alcohol for 2 minutes each for 2 
times. Before transferring them into 95% alcohol for 2 minutes, the slides were put 
into methanol/hydrogen peroxide for 30 minutes in order to remove any 
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endogenous peroxidase. After this step, the slides are washed in running water for 5 
minutes. 
 Depending on the antibody, some slides were pretreated with a different 
buffered saline or formic acid. After pretreatment, the slides were washed in 
running water for 5 minutes before transferring into phosphate buffer saline (PBS) 
Once a circle was drawn around the tissue section with a Pap marker pen, the 
section was blocked with a ScyTek superblock for 5 minutes. After blocking, the first 
antibody was dropped onto the section and left at 4° Celsius overnight or for two 
days. 
 After the section was removed and back at room temperature, it was rinsed 3 
times in PBS for a total of 10 minutes. Then the second antibody is added onto the 
section before rinsing it with PBS for a period of 10 minutes. The amino ethyl 
carbazole (AEC) substrate was dropped onto the slide until the sections became well 
developed with a red stain. The section was then counterstained in Gill Hematoxylin 
for about 15 dips depending on how often the hematoxylin has been used before. It 
was then washed in running water for 5 minutes. After washing, a cover slip was 
placed onto the section with an aqueous mounting medium. Once the section was 
dried at 60°C for about 30 minutes or until completely dry, the section was placed in 
xylene. Finally, a coverslip was added to the section by using 2 drops of consul-
mount. After the slides were prepared, they were extensively examined under a Nikon 
optiphot-2 microscope at 20x and 40x magnification in order to find pathology associated 
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with CTE. The antibodies used in this study were pTDP-43, P62, αβ crystalline, and 
CP13. 
 
pTDP-43 
 PTDP-43 is a nuclear protein that has an important role in transcription and 
mRNA splicing (Mizuno et al., 2012). The dilution used for this antibody is 1:2000 and 
the antibody was pretreated in formic acid for 2 minutes. The positivity of PTDP-43 can 
be seen in three different types of inclusions: dot-like inclusions, round inclusions, and 
skein-like inclusions (Mizuno et al., 2012). The inclusions tend to have a red or brown 
hue.  
 
p62 
 P62 is a nucleoporin that plays a role in exporting mRNA from the nucleus 
(Dargemont et al., 1995). The dilution used for p62 was 1:1000 and the pretreatment of 
the antibody is heat-induced epitope retrieval (HIER) in a tris-buffered saline (TBS) at a 
pH of 9 for 15 minutes. The positivity of p62 can be seen around the nucleus of the cells 
and has a brown/red hue that is similar to that seen in pTDP-43 positivity.  
 
αβ crystallin 
 αβ crystallin functions as a cellular chaperone that works to prevent the 
aggregation of proteins (Piri et al., 2013). It is part of the cellular defense system and is 
usually upregulated as a response to some form of stress on the tissues (Piri et al., 2013).  
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The upregualtion of αβ crystallin has been seen in many neurodegenerative diseases such 
as Alzheimer’s disease and Parkinson’s disease (Piri et al., 2013). The dilution used for 
αβ crystalline was 1:14000 with a pretreatment of 2 minutes in formic acid.  
 
CP13 
 CP13 is a non-commercial antibody that was obtained from Dr. Peter Davies at 
Albert Einstein College of Medicine. It is an antibody directed at phosphorylated tau at 
the epitope pSer202 at a dilution of 1:1000. As with the other antibodies used in this study, 
CP13 positivity has a brown or red hue 
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RESULTS 
 Dr. Ann McKee previously diagnosed each of the cases used in this study 
through pathological examination of the brain tissue.  The ages of the individuals 
used in this study ranged from 31 to 93 with the average age being 63, with the 
gender all ten individuals male. Three of the cases used were diagnosed as CTEM, 
which is CTE along with MND.  
 
Table 1: Diagnosis of 10 cases used in study. This table shows the data collected 
from the post-mortem investigations of the 10 cases whose eyes were used in this 
study. It contains the age and gender of the individual along with their diagnosis.  
 
CASE AGE DIAGNOSIS GENDER 
SLI 54 31 CTE stage 2, CTEM M 
SLI 57 41 CTE stage 2, CTEM M 
SLI 63 49 CTE stage 2 M 
SLI 64 80 CTE stage 4 M 
SLI 83 67 CTE stage 3, CTEM M 
SLI 96 93 CTE stage 4 M 
SLI 128 79 CTE stage 4 M 
SLI 137 61 CTE stage 3 M 
SLI 124 52 CTE stage 2 M 
SLI 157 77 CTE stage 4 M 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 5: % of Cases with Various Stages of CTE
diagnosed with each case of CTE used in this study. The graph shows 40% of people 
were diagnosed with stage 2 CTE, 20% were diagnosed with stage 3 CTE, and 40% were 
diagnosed with stage 4 CTE. 30% of the cases used in th
with CTEM.  
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dot-like inclusions throughout multiple layers of the retina. The final case, SLI 157, 
showed a large amount of positivity in the GCL that consisted of both round and skein-
like inclusions. This case looked to be the most positive.  
 SLI 63 and SLI 83 do not show strong enough pTDP-43 pathology and thus will 
be considered negative. SLI 63 was a less severe case of CTE, which could be indicative 
of why there is no pathology seen in the retina. A reason for why SLI 83 does not show 
much positivity could be due to the pathology that is occurring in the brain. If the 
pathology in the brain is not severe then the lack of pathology in the eye follows that 
pattern. However, as the stages become more severe, the pathology also becomes more 
severe as well.  
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Figure 6: Images of cases positive for pTDP-43. This figure shows images of the 8 
cases that proved to be positive for pTDP-43. The arrows point to areas that exhibit the 
pTDP-43 pathology. 
 
 
 
  
Figure 7: % of cases positive for pTDP
were positive for pTDP-43 while only 50% of stage 3 CTE were positive. 100% of stage 
4 cases were positive while 66% of CTEM cases were positive. 
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GCL. SLI 137 had positivity in both the GCL and INL. As with the pTDP43 stain, SLI 
157 has the most severe pathology. There is positivity in the GCL, INL, and ONL. 
Every case, regardless of CTE stage, showed p62 pathology with the most severe 
pathology occurring in the GCL. Although every case showed positivity, the stage 4 
cases showed the most intense pathology that spanned multiple layers of the retina. The 
pathology seen in p62 follows the same pattern as pTDP-43 pathology which shows that 
the more severe the stage of CTE, the more severe the pathology.  
 
 29 
 
 
Figure 8: Images of cases positive for p62 pathology. This figure shows images of the 
10 cases that proved to be positive for 62. The arrows point to areas that exhibit the p62 
pathology 
  
Figure 9: % of cases positive for p62
according to stage, that are positive for p62. This is very interesting as all cases showed 
positivity. It is important to note that although there is positivity in each case, the degree 
of positivity differed according to stage. For example, SLI 157 (Stage 4) exhibited in 
strong positivity throughout multiple layers of the retina.
pathology in the more severe cases. 
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ONL while SLI 157 shows intense positivity in a cell layer that is difficult to identify due 
to the section.  
 
Figure 10: Images of cases positive for αβ crystallin. The above images are the cases 
that show positivity for αβ crystallin. Arrows point to areas affected.  
  
Figure 11: % of cases positive for 
each stage of CTE with the highest positivity seen in stage 2 CTE individuals. 
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that looks similar to the positivity seen in SLI 64. SLI 124 also exhibits positivity in the 
GCL. Both SLI 128 and SLI 137 looked negative while SLI 157 showed strong positivity 
in both the GCL and INL. 
 
Figure 12: Images of cases positive for CP13. This figure shows the images of the 7 
cases that show positivity for CP13. 
  
 
Figure 13: % of cases positive for CP13
positive for CP13.  
 
 The results for CP13 are very similar to the results seen in pTDP
stage 4 cases show positivity for CP13, which is indicative of the presence of tau protein. 
These results are consistent with the idea that there is an increase in the severity o
pathology when there is an increased severity of disease. Therefore, it makes sense that 
100 % of the cases show presence of tau protein, as hyperphosphorylated tau is a major 
component of CTE.   
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DISCUSSION 
 
 The results obtained from this research serve as an excellent foundation for 
further research of the eye and its connection to pathology seen in CTE. The 
positivity of pTDP-43 and CP13 show that tau protein does indeed manifest itself in 
the retina in chronic traumatic encephalopathy. Stage 4 CTE eyes showed 100% 
positivity for both pTDP-43 and CP13 which indicates that the pathology seen in the 
eye shadows the pathology occurring in the brain. All of the cases show p62 
pathology with the most severe pathology occurring in the higher stage cases, which 
follows the pattern seen with both pTDP-43 and CP13. Αβ crystallin, however, 
displayed a different pattern. The stage 2 cases showed strong positivity while the 
stage 4 cases had a very small amount of positivity if any. This may be explained by 
the fact that αβ crystallin is upregulated in the tissues when there is insult or injury. 
There may be a stronger presence of αβ crystallin in stage 2 because the tissues are 
beginning to notice the disease starting to progress while stage 4 is too far-gone and 
the defense mechanism is no longer effective. Therefore, the stage 4 cases do not 
show a strong positivity of αβ crystallin, 
There is important social and clinical significance to further research of 
chronic traumatic encephalopathy. Concussions are very common in contact sports 
with at least 1.6 to 3.8 million concussions per year in the United States with 
statistics showing that at least 17% of people who suffer repetitive concussions will 
develop CTE (McKee et al., 2009). As this disease gains more attention and more 
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research, Most of the CTE attention in today’s media is towards professional athletes 
or those of a celebrity status. Unfortunately, many of theses professional athletes 
began their athletic career at a young age and most likely suffered from concussive 
and subconcussive injuries as a child. This leads to curiosity about whether children 
are more at risk than adults.  
 In the past, research claimed that a child’s brain could undergo trauma but 
could heal due to a high plasticity (Stern et al., 2011). Therefore, the recovery would 
be faster and the damage would not be as severe. However, recent studies show that 
this is incorrect. A brain of a younger person may be more likely to suffer from brain 
injury and will have a more difficult recovery along with potential developmental 
issues (Stern et al., 2011). CTE research allows the public to understand the risks of 
concussions and makes way for safer and better protection of athletes both amateur 
and professional.  
 The future direction of ophthalmological research relating to CTE can 
go many different ways.  This research focused primarily on the retina and the 
layers that comprise it but it may be beneficial to research the optic nerve and see if 
the results are similar. Also, all of the individuals in this research were male. It 
would be interesting to see if these same results were seen in the eyes of females 
who suffered from CTE. 
As of right now, CTE can only be diagnosed by looking at the brain tissue 
after an individual has died. Since the retina of the eye is an extension of the CNS, 
 37 
 
there is strong clinical significance in looking at the eyes as a diagnosis for 
individuals currently suffering from chronic traumatic encephalopathy. As shown in 
the above research, the retina is indicative of what is occurring in the brain. 
Therefore, it is a very useful tool in advancing our knowledge of CTE. It gives the 
potential to diagnose while the individual is still alive and makes treatment a 
possibility.   
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